CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
53,077,474
Share change
+11,641,450
Total reported value
$127,388,870
Price per share
$2.40
Number of holders
80
Value change
+$27,900,830
Number of buys
46
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q1 2021

As of 31 Mar 2021, CASI PHARMACEUTICALS INC - COM (CASI) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,077,474 shares. The largest 10 holders included Consonance Capital Management LP, FEDERATED HERMES, INC., IDG-Accel China Growth Fund III Associates L.P., VANGUARD GROUP INC, BlackRock Inc., Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, Tri Locum Partners LP, Ikarian Capital, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 80 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.